Review article · 2021 · Open access
Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability
Clinical Pharmacology & Therapeutics, 110(3), 626–636 · Published 10 June 2021 · DOI 10.1002/cpt.2289
In brief
“Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability” is a 2021 review article by Yitian Zhou and Volker Martin Lauschke, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 39 citations as of 21 November 2026, which puts it in the top 4% of works published in 2021 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 39
- Most cited in
- 2024 (9)
- Field-weighted impact
- 0.92
- References
- 101
- Authors
- 2
Abstract
Interindividual differences in drug response are a common concern in both drug development and across layers of care. While genetics clearly influences drug response and toxicity of many drugs, a substantial fraction of the heritable pharmacological and toxicological variability remains unexplained by known genetic polymorphisms. In recent years, population-scale sequencing projects have unveiled tens of thousands of coding and noncoding pharmacogenetic variants with unclear functional effects that might explain at least part of this missing heritability. However, translating these personalized variant signatures into drug response predictions and actionable advice remains challenging and constitutes one of the most important frontiers of contemporary pharmacogenomics. Conventional prediction methods are primarily based on evolutionary conservation, which drastically reduces their predictive accuracy when applied to poorly conserved pharmacogenes. Here, we review the current state-of-the-art of computational variant effect predictors across variant classes and critically discuss their utility for pharmacogenomics. Besides missense variants, we discuss recent progress in the evaluation of synonymous, splice, and noncoding variations. Furthermore, we discuss emerging possibilities to assess haplotypes and structural variations. We advocate for the development of algorithms trained on pharmacogenomic instead of pathogenic data sets to improve the predictive accuracy in order to facilitate the utilization of next-generation sequencing data for personalized clinical decision support and precision pharmacogenomics.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zhou, Y., & Lauschke, V. M. (2021). Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability. Clinical Pharmacology & Therapeutics, 110(3), 626–636. https://doi.org/10.1002/cpt.2289
MLA 9
Zhou, Yitian, and Volker Martin Lauschke. “Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.” Clinical Pharmacology & Therapeutics, vol. 110, no. 3, 2021, pp. 626–636. https://doi.org/10.1002/cpt.2289.
Chicago
Zhou, Yitian and Volker Martin Lauschke. 2021. “Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.” Clinical Pharmacology & Therapeutics 110 (3): 626–636. https://doi.org/10.1002/cpt.2289.
Harvard
Zhou, Y. and Lauschke, V. M. (2021) ‘Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability’, Clinical Pharmacology & Therapeutics, 110(3), pp. 626–636. doi:10.1002/cpt.2289.
IEEE
Y. Zhou and V. M. Lauschke, “Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability,” Clinical Pharmacology & Therapeutics, vol. 110, no. 3, pp. 626–636, 2021, doi: 10.1002/cpt.2289.
BibTeX
@article{zhou2021computational,
title = {{Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability}},
author = {Zhou, Yitian and Lauschke, Volker Martin},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2021},
volume = {110},
number = {3},
pages = {626--636},
doi = {10.1002/cpt.2289},
url = {https://doi.org/10.1002/cpt.2289}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 4 | |
| 2022 | 8 | |
| 2023 | 6 | |
| 2024 | 9 | |
| 2025 | 5 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.92: it has been cited 0.92 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- variant effect prediction
- non-coding variants
- rare variants
- missing heritability
- drug response prediction
- synonymous mutations
- splice variants
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Zhou, Y., & Lauschke, V. M. (2021). Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability. Clinical Pharmacology & Therapeutics, 110(3), 626–636. https://doi.org/10.1002/cpt.2289
How many times has this paper been cited?
39 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the full text from this page.
Who wrote this paper?
Yitian Zhou, Volker Martin Lauschke.
What is the DOI of this paper?
10.1002/cpt.2289, permanently at https://doi.org/10.1002/cpt.2289. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.